

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | notochord development (GO:0030903) | 7.91101723 |
| 2 | * sphingosine metabolic process (GO:0006670) | 7.73637043 |
| 3 | surfactant homeostasis (GO:0043129) | 7.59599833 |
| 4 | thrombin receptor signaling pathway (GO:0070493) | 7.45650087 |
| 5 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 7.29313248 |
| 6 | regulation of translational termination (GO:0006449) | 7.28135320 |
| 7 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 7.18054159 |
| 8 | regulation of meiosis I (GO:0060631) | 7.09514394 |
| 9 | * diol metabolic process (GO:0034311) | 6.97505210 |
| 10 | regulation of endothelial cell differentiation (GO:0045601) | 6.96385522 |
| 11 | piRNA metabolic process (GO:0034587) | 6.92550960 |
| 12 | protein-chromophore linkage (GO:0018298) | 6.71585710 |
| 13 | * sphingoid metabolic process (GO:0046519) | 6.69114989 |
| 14 | positive regulation of endothelial cell differentiation (GO:0045603) | 6.54250029 |
| 15 | negative regulation of cAMP-mediated signaling (GO:0043951) | 6.41046432 |
| 16 | DNA methylation involved in gamete generation (GO:0043046) | 6.23017619 |
| 17 | lipopolysaccharide biosynthetic process (GO:0009103) | 6.16682752 |
| 18 | lymph vessel development (GO:0001945) | 6.10459556 |
| 19 | lymphangiogenesis (GO:0001946) | 6.05173140 |
| 20 | chemical homeostasis within a tissue (GO:0048875) | 5.95933885 |
| 21 | blood vessel maturation (GO:0001955) | 5.60431462 |
| 22 | regulation of pigment cell differentiation (GO:0050932) | 5.57264803 |
| 23 | endothelium development (GO:0003158) | 5.44905270 |
| 24 | positive regulation of vasculogenesis (GO:2001214) | 5.35647182 |
| 25 | morphogenesis of an endothelium (GO:0003159) | 5.34699988 |
| 26 | endothelial tube morphogenesis (GO:0061154) | 5.34699988 |
| 27 | SMAD protein complex assembly (GO:0007183) | 5.31383014 |
| 28 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.31356024 |
| 29 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.30203787 |
| 30 | opioid receptor signaling pathway (GO:0038003) | 5.28574669 |
| 31 | positive regulation of developmental pigmentation (GO:0048087) | 5.26318443 |
| 32 | ether lipid metabolic process (GO:0046485) | 5.25977625 |
| 33 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 5.23063251 |
| 34 | lipopolysaccharide metabolic process (GO:0008653) | 5.21591438 |
| 35 | nodal signaling pathway (GO:0038092) | 5.11548813 |
| 36 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.06087830 |
| 37 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.04342861 |
| 38 | regulation of vasculogenesis (GO:2001212) | 4.96208329 |
| 39 | adult feeding behavior (GO:0008343) | 4.88509899 |
| 40 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.77183573 |
| 41 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.74453813 |
| 42 | sulfate transmembrane transport (GO:1902358) | 4.66637943 |
| 43 | behavioral response to ethanol (GO:0048149) | 4.63598208 |
| 44 | L-phenylalanine catabolic process (GO:0006559) | 4.57933685 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.57933685 |
| 46 | regulation of odontogenesis (GO:0042481) | 4.57322805 |
| 47 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.50051535 |
| 48 | endothelial cell differentiation (GO:0045446) | 4.43001772 |
| 49 | heme transport (GO:0015886) | 4.41992289 |
| 50 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.26854463 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.25534679 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 4.25534679 |
| 53 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.24190441 |
| 54 | tyrosine metabolic process (GO:0006570) | 4.10084149 |
| 55 | sulfate transport (GO:0008272) | 4.06477243 |
| 56 | negative regulation of neural precursor cell proliferation (GO:2000178) | 4.04418025 |
| 57 | artery development (GO:0060840) | 4.01898047 |
| 58 | ovulation from ovarian follicle (GO:0001542) | 3.92747303 |
| 59 | endothelial cell morphogenesis (GO:0001886) | 3.88508827 |
| 60 | venous blood vessel morphogenesis (GO:0048845) | 3.87757391 |
| 61 | one-carbon compound transport (GO:0019755) | 3.85292949 |
| 62 | ribonucleoprotein complex disassembly (GO:0032988) | 3.80218579 |
| 63 | signal complex assembly (GO:0007172) | 3.77576476 |
| 64 | negative regulation of stem cell proliferation (GO:2000647) | 3.72441609 |
| 65 | embryonic process involved in female pregnancy (GO:0060136) | 3.70554165 |
| 66 | lung vasculature development (GO:0060426) | 3.70142547 |
| 67 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.68791493 |
| 68 | renal filtration (GO:0097205) | 3.68596437 |
| 69 | vitamin transmembrane transport (GO:0035461) | 3.67539556 |
| 70 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.64653006 |
| 71 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.60059348 |
| 72 | regulation of acrosome reaction (GO:0060046) | 3.59679062 |
| 73 | positive regulation of meiosis (GO:0045836) | 3.59199325 |
| 74 | biotin metabolic process (GO:0006768) | 3.58431389 |
| 75 | wound healing, spreading of epidermal cells (GO:0035313) | 3.57621486 |
| 76 | gap junction assembly (GO:0016264) | 3.56456875 |
| 77 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.56189699 |
| 78 | glomerular filtration (GO:0003094) | 3.54610643 |
| 79 | meiotic chromosome segregation (GO:0045132) | 3.51033329 |
| 80 | homocysteine metabolic process (GO:0050667) | 3.49951524 |
| 81 | response to nitrosative stress (GO:0051409) | 3.49001527 |
| 82 | regulation of interleukin-5 production (GO:0032674) | 3.48486623 |
| 83 | positive regulation of meiotic cell cycle (GO:0051446) | 3.47127953 |
| 84 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.44041985 |
| 85 | negative regulation of DNA biosynthetic process (GO:2000279) | 3.42159789 |
| 86 | sprouting angiogenesis (GO:0002040) | 3.39070798 |
| 87 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.38851321 |
| 88 | cellular response to nitric oxide (GO:0071732) | 3.33245080 |
| 89 | rhodopsin mediated signaling pathway (GO:0016056) | 3.30171779 |
| 90 | DNA integration (GO:0015074) | 3.29905549 |
| 91 | response to epinephrine (GO:0071871) | 3.23614631 |
| 92 | vasculogenesis (GO:0001570) | 3.23352979 |
| 93 | regulation of keratinocyte proliferation (GO:0010837) | 3.23290306 |
| 94 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.21785186 |
| 95 | patterning of blood vessels (GO:0001569) | 3.21139677 |
| 96 | tachykinin receptor signaling pathway (GO:0007217) | 3.18240398 |
| 97 | lung lobe morphogenesis (GO:0060463) | 3.13706701 |
| 98 | urate metabolic process (GO:0046415) | 3.09449693 |
| 99 | blood vessel remodeling (GO:0001974) | 3.07143510 |
| 100 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.05562894 |
| 101 | fibroblast migration (GO:0010761) | 3.04052255 |
| 102 | glycerol metabolic process (GO:0006071) | 3.03012667 |
| 103 | endothelial cell proliferation (GO:0001935) | 3.02979704 |
| 104 | cellular response to reactive nitrogen species (GO:1902170) | 2.97953445 |
| 105 | negative regulation of protein autophosphorylation (GO:0031953) | 2.97907134 |
| 106 | xenobiotic catabolic process (GO:0042178) | 2.97777454 |
| 107 | serotonin receptor signaling pathway (GO:0007210) | 2.96951847 |
| 108 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.95741389 |
| 109 | protein retention in ER lumen (GO:0006621) | 2.93682582 |
| 110 | blood vessel endothelial cell migration (GO:0043534) | 2.91910217 |
| 111 | establishment of apical/basal cell polarity (GO:0035089) | 2.91493753 |
| 112 | negative regulation of platelet activation (GO:0010544) | 2.91163187 |
| 113 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.88569373 |
| 114 | regulation of cAMP-mediated signaling (GO:0043949) | 2.88101170 |
| 115 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 2.85914802 |
| 116 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.84251196 |
| 117 | cellular response to gamma radiation (GO:0071480) | 2.83471892 |
| 118 | basement membrane organization (GO:0071711) | 2.82704754 |
| 119 | germinal center formation (GO:0002467) | 2.82651814 |
| 120 | ganglion development (GO:0061548) | 2.80847607 |
| 121 | hippo signaling (GO:0035329) | 2.80235974 |
| 122 | iron coordination entity transport (GO:1901678) | 2.79432727 |
| 123 | flavonoid metabolic process (GO:0009812) | 2.79317222 |
| 124 | endoderm development (GO:0007492) | 2.78462005 |
| 125 | centriole replication (GO:0007099) | 2.76007834 |
| 126 | alditol metabolic process (GO:0019400) | 2.75640714 |
| 127 | gene silencing by RNA (GO:0031047) | 2.74063347 |
| 128 | negative regulation of focal adhesion assembly (GO:0051895) | 2.73395200 |
| 129 | negative regulation of cell junction assembly (GO:1901889) | 2.73395200 |
| 130 | negative regulation of adherens junction organization (GO:1903392) | 2.73395200 |
| 131 | paraxial mesoderm development (GO:0048339) | 2.73243613 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 2.71269165 |
| 133 | response to mercury ion (GO:0046689) | 2.69742117 |
| 134 | superoxide anion generation (GO:0042554) | 2.69204963 |
| 135 | positive regulation of urine volume (GO:0035810) | 2.68892397 |
| 136 | positive regulation of digestive system process (GO:0060456) | 2.67836119 |
| 137 | heart trabecula morphogenesis (GO:0061384) | 2.66782390 |
| 138 | fatty acid transmembrane transport (GO:1902001) | 2.66126968 |
| 139 | epithelial cell-cell adhesion (GO:0090136) | 2.65395224 |
| 140 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.65375470 |
| 141 | negative regulation of endothelial cell migration (GO:0010596) | 2.65328334 |
| 142 | pantothenate metabolic process (GO:0015939) | 2.64534609 |
| 143 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.64316957 |
| 144 | sympathetic nervous system development (GO:0048485) | 2.63943804 |
| 145 | SMAD protein signal transduction (GO:0060395) | 2.63530459 |
| 146 | negative regulation of cell fate specification (GO:0009996) | 2.63193685 |
| 147 | atrial cardiac muscle cell action potential (GO:0086014) | 2.62895693 |
| 148 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.62285165 |
| 149 | heart valve formation (GO:0003188) | 2.61818536 |
| 150 | establishment of skin barrier (GO:0061436) | 2.60923334 |
| 151 | renal absorption (GO:0070293) | 2.59061017 |
| 152 | sodium-independent organic anion transport (GO:0043252) | 2.58446660 |
| 153 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.57756987 |
| 154 | regulation of hair follicle development (GO:0051797) | 2.57505051 |
| 155 | polyol transport (GO:0015791) | 2.56842543 |
| 156 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.56033859 |
| 157 | regulation of gonadotropin secretion (GO:0032276) | 2.55935151 |
| 158 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55769976 |
| 159 | response to xenobiotic stimulus (GO:0009410) | 2.55643032 |
| 160 | glomerular basement membrane development (GO:0032836) | 2.54919568 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.54827861 |
| 162 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.54432527 |
| 163 | cGMP-mediated signaling (GO:0019934) | 2.52538236 |
| 164 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.52517541 |
| 165 | kinetochore assembly (GO:0051382) | 2.52376313 |
| 166 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.52209279 |
| 167 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.49507312 |
| 168 | transcytosis (GO:0045056) | 2.47682578 |
| 169 | negative regulation of mast cell activation (GO:0033004) | 2.45213463 |
| 170 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44980211 |
| 171 | ovulation (GO:0030728) | 2.44609532 |
| 172 | tonic smooth muscle contraction (GO:0014820) | 2.41267207 |
| 173 | regulation of cellular extravasation (GO:0002691) | 2.38172073 |
| 174 | Notch signaling involved in heart development (GO:0061314) | 2.38123510 |
| 175 | trabecula morphogenesis (GO:0061383) | 2.37304887 |
| 176 | regulation of cardioblast differentiation (GO:0051890) | 2.35155739 |
| 177 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.32784166 |
| 178 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.32178295 |
| 179 | axon extension involved in axon guidance (GO:0048846) | 2.32178295 |
| 180 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.32086641 |
| 181 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.30379759 |
| 182 | mammary gland development (GO:0030879) | 2.30060405 |
| 183 | negative regulation of epithelial cell differentiation (GO:0030857) | 2.29413344 |
| 184 | response to nitric oxide (GO:0071731) | 2.28609471 |
| 185 | establishment of monopolar cell polarity (GO:0061162) | 2.26767727 |
| 186 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.26767727 |
| 187 | facial nerve structural organization (GO:0021612) | 2.26694987 |
| 188 | regulation of urine volume (GO:0035809) | 2.25800097 |
| 189 | regulation of glomerular filtration (GO:0003093) | 2.25660841 |
| 190 | negative regulation of epithelial cell migration (GO:0010633) | 2.25408540 |
| 191 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.24326059 |
| 192 | glomerular visceral epithelial cell development (GO:0072015) | 2.24236371 |
| 193 | drug metabolic process (GO:0017144) | 2.23961095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89697108 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.23372206 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.06567536 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.77957337 |
| 5 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.61314648 |
| 6 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.61314648 |
| 7 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.61314648 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.29562671 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.27763964 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.06301008 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.03372326 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 3.02081733 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85046903 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.76628562 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.74768265 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52848006 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46361468 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38906835 |
| 19 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.35646537 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.35070802 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34051608 |
| 22 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.22975781 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.19545663 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19496994 |
| 25 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06057424 |
| 26 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 2.06057424 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.05094986 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.01668644 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.01125053 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.00267055 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.98796178 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98765705 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.97461665 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.94076221 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90684523 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90632230 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88201275 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.86855030 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.86811290 |
| 40 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.85531144 |
| 41 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.84601727 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.82276332 |
| 43 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.82036859 |
| 44 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.80057987 |
| 45 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.77136063 |
| 46 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76879148 |
| 47 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.75996806 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73915404 |
| 49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.73422076 |
| 50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.73243061 |
| 51 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.72879283 |
| 52 | RXR_22108803_ChIP-Seq_LS180_Human | 1.72195466 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70931752 |
| 54 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.68098478 |
| 55 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.66867738 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.66312560 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.66252989 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.66048815 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64583323 |
| 60 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.60370461 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59361178 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.54176082 |
| 63 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.53718227 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52126609 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.51867562 |
| 66 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.51158041 |
| 67 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.51158041 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51077526 |
| 69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.50714273 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50449555 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.50185759 |
| 72 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.46074121 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.45730552 |
| 74 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41185961 |
| 75 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.40611888 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40127920 |
| 77 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.39522262 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39443129 |
| 79 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39249855 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.38186420 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.38147523 |
| 82 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37032939 |
| 83 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35435611 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34403647 |
| 85 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34338648 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.33390787 |
| 87 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.32934436 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32904738 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.32633980 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30801083 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.30411380 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.28949406 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26232401 |
| 94 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24998495 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24555138 |
| 96 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.24466387 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21199114 |
| 98 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20619634 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19245068 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18938340 |
| 101 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.18695096 |
| 102 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18241013 |
| 103 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16682067 |
| 104 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.16273662 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16126318 |
| 106 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.14937530 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.14698295 |
| 108 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.14354420 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13518606 |
| 110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13073909 |
| 111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.12550521 |
| 112 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.11241285 |
| 113 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10499041 |
| 114 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10449500 |
| 115 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.10008078 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09739871 |
| 117 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.09484726 |
| 118 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.07830459 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06816802 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.06431858 |
| 121 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.06335783 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05880009 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05576155 |
| 124 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05552001 |
| 125 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.05169738 |
| 126 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05164559 |
| 127 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04868513 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03857872 |
| 129 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.01923142 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01858254 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 1.01774419 |
| 132 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01771985 |
| 133 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.01560441 |
| 134 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01538511 |
| 135 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01112702 |
| 136 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01098372 |
| 137 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.00468500 |
| 138 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00070269 |
| 139 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.99153352 |
| 140 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98979592 |
| 141 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.98657340 |
| 142 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.98119513 |
| 143 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97075064 |
| 144 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96618724 |
| 145 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.96484872 |
| 146 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96251693 |
| 147 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.95918567 |
| 148 | * OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.95542436 |
| 149 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95536476 |
| 150 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95113543 |
| 151 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94286317 |
| 152 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.93739640 |
| 153 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93626655 |
| 154 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93319835 |
| 155 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93319835 |
| 156 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92927698 |
| 157 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.92831033 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92179053 |
| 159 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.91585273 |
| 160 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91521802 |
| 161 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89881132 |
| 162 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89042614 |
| 163 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89042614 |
| 164 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89013203 |
| 165 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87810994 |
| 166 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86804511 |
| 167 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.86114878 |
| 168 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.84667352 |
| 169 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.84397849 |
| 170 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83748907 |
| 171 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.82806535 |
| 172 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.82381881 |
| 173 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.82246556 |
| 174 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.81107140 |
| 175 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.80777015 |
| 176 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80576144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.92130972 |
| 2 | MP0010368_abnormal_lymphatic_system | 6.32219304 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 4.93079702 |
| 4 | MP0003045_fibrosis | 4.83204879 |
| 5 | MP0002653_abnormal_ependyma_morphology | 4.37396190 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 4.28940865 |
| 7 | MP0005670_abnormal_white_adipose | 3.71545781 |
| 8 | MP0003879_abnormal_hair_cell | 3.63479486 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.43769176 |
| 10 | MP0004272_abnormal_basement_membrane | 3.31214254 |
| 11 | MP0009780_abnormal_chondrocyte_physiolo | 3.05047176 |
| 12 | MP0003646_muscle_fatigue | 2.95435134 |
| 13 | MP0004782_abnormal_surfactant_physiolog | 2.94449939 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.94139025 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.78511598 |
| 16 | MP0003724_increased_susceptibility_to | 2.61535531 |
| 17 | MP0004381_abnormal_hair_follicle | 2.58909443 |
| 18 | MP0005367_renal/urinary_system_phenotyp | 2.54734598 |
| 19 | MP0000516_abnormal_urinary_system | 2.54734598 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.51601394 |
| 21 | MP0003828_pulmonary_edema | 2.45001397 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.32555767 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.21798968 |
| 24 | MP0008995_early_reproductive_senescence | 2.11004528 |
| 25 | MP0003941_abnormal_skin_development | 2.06135153 |
| 26 | MP0004084_abnormal_cardiac_muscle | 2.03661066 |
| 27 | MP0002168_other_aberrant_phenotype | 2.03024293 |
| 28 | MP0002132_abnormal_respiratory_system | 1.97148094 |
| 29 | MP0009697_abnormal_copulation | 1.84154564 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.78357641 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.68342976 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.68015101 |
| 33 | MP0008004_abnormal_stomach_pH | 1.66769444 |
| 34 | MP0004233_abnormal_muscle_weight | 1.66052056 |
| 35 | MP0000749_muscle_degeneration | 1.64199581 |
| 36 | MP0004147_increased_porphyrin_level | 1.60710725 |
| 37 | MP0006054_spinal_hemorrhage | 1.58585774 |
| 38 | MP0002277_abnormal_respiratory_mucosa | 1.54636757 |
| 39 | MP0001188_hyperpigmentation | 1.52477291 |
| 40 | MP0006138_congestive_heart_failure | 1.52262928 |
| 41 | MP0005595_abnormal_vascular_smooth | 1.47663615 |
| 42 | MP0000767_abnormal_smooth_muscle | 1.47605774 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.47425579 |
| 44 | MP0002127_abnormal_cardiovascular_syste | 1.44298300 |
| 45 | MP0001958_emphysema | 1.40323974 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.39062594 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.38449780 |
| 48 | MP0005165_increased_susceptibility_to | 1.37580240 |
| 49 | MP0003718_maternal_effect | 1.36533433 |
| 50 | MP0000343_altered_response_to | 1.35976792 |
| 51 | MP0005360_urolithiasis | 1.35706339 |
| 52 | MP0005365_abnormal_bile_salt | 1.34907955 |
| 53 | MP0002796_impaired_skin_barrier | 1.31074186 |
| 54 | MP0000566_synostosis | 1.29343290 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.27988314 |
| 56 | MP0002971_abnormal_brown_adipose | 1.27556302 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.25389800 |
| 58 | MP0004484_altered_response_of | 1.22737979 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.22688867 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.22485710 |
| 61 | MP0001756_abnormal_urination | 1.21865058 |
| 62 | MP0005501_abnormal_skin_physiology | 1.19893559 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18280399 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.17334832 |
| 65 | MP0003186_abnormal_redox_activity | 1.13446415 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.12108099 |
| 67 | MP0010030_abnormal_orbit_morphology | 1.11227116 |
| 68 | MP0009764_decreased_sensitivity_to | 1.10477559 |
| 69 | MP0003786_premature_aging | 1.10112010 |
| 70 | MP0000249_abnormal_blood_vessel | 1.09261404 |
| 71 | MP0004130_abnormal_muscle_cell | 1.07713613 |
| 72 | MP0004215_abnormal_myocardial_fiber | 1.06797062 |
| 73 | MP0005171_absent_coat_pigmentation | 1.06413134 |
| 74 | MP0005385_cardiovascular_system_phenoty | 1.04944939 |
| 75 | MP0001544_abnormal_cardiovascular_syste | 1.04944939 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.04438859 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.03637362 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 1.03137601 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.02970279 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 1.02482405 |
| 81 | MP0003890_abnormal_embryonic-extraembry | 1.02157679 |
| 82 | MP0004133_heterotaxia | 1.00784212 |
| 83 | MP0003959_abnormal_lean_body | 1.00556887 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.99891241 |
| 85 | MP0005330_cardiomyopathy | 0.99616148 |
| 86 | MP0005076_abnormal_cell_differentiation | 0.96469794 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.92621609 |
| 88 | MP0002925_abnormal_cardiovascular_devel | 0.88941778 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.87522717 |
| 90 | MP0009643_abnormal_urine_homeostasis | 0.87476477 |
| 91 | MP0001968_abnormal_touch/_nociception | 0.87455123 |
| 92 | MP0005083_abnormal_biliary_tract | 0.87424977 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.86730549 |
| 94 | MP0008058_abnormal_DNA_repair | 0.85086882 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.84790748 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.83526352 |
| 97 | MP0005647_abnormal_sex_gland | 0.83328201 |
| 98 | MP0003567_abnormal_fetal_cardiomyocyte | 0.82946741 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.82800194 |
| 100 | MP0003119_abnormal_digestive_system | 0.82561441 |
| 101 | MP0001664_abnormal_digestion | 0.81713203 |
| 102 | MP0008057_abnormal_DNA_replication | 0.81683210 |
| 103 | MP0002128_abnormal_blood_circulation | 0.81589850 |
| 104 | MP0005332_abnormal_amino_acid | 0.81072986 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.80757477 |
| 106 | MP0002133_abnormal_respiratory_system | 0.79920360 |
| 107 | MP0005388_respiratory_system_phenotype | 0.79920360 |
| 108 | MP0001614_abnormal_blood_vessel | 0.79438912 |
| 109 | MP0003984_embryonic_growth_retardation | 0.78632310 |
| 110 | MP0004264_abnormal_extraembryonic_tissu | 0.78537066 |
| 111 | MP0005409_darkened_coat_color | 0.77560762 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.77201243 |
| 113 | MP0001545_abnormal_hematopoietic_system | 0.77201243 |
| 114 | MP0003195_calcinosis | 0.77065960 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.76893883 |
| 116 | MP0002088_abnormal_embryonic_growth/wei | 0.75884597 |
| 117 | MP0001672_abnormal_embryogenesis/_devel | 0.75671017 |
| 118 | MP0005380_embryogenesis_phenotype | 0.75671017 |
| 119 | MP0008874_decreased_physiological_sensi | 0.75362494 |
| 120 | MP0004883_abnormal_blood_vessel | 0.74492427 |
| 121 | MP0002086_abnormal_extraembryonic_tissu | 0.74433018 |
| 122 | MP0010771_integument_phenotype | 0.74054995 |
| 123 | MP0002075_abnormal_coat/hair_pigmentati | 0.73599655 |
| 124 | MP0002160_abnormal_reproductive_system | 0.73149283 |
| 125 | MP0001764_abnormal_homeostasis | 0.72999389 |
| 126 | MP0005395_other_phenotype | 0.72127702 |
| 127 | MP0003638_abnormal_response/metabolism_ | 0.70949606 |
| 128 | MP0002095_abnormal_skin_pigmentation | 0.70255333 |
| 129 | MP0003111_abnormal_nucleus_morphology | 0.69360034 |
| 130 | MP0000534_abnormal_ureter_morphology | 0.68712474 |
| 131 | MP0003011_delayed_dark_adaptation | 0.68468866 |
| 132 | MP0009278_abnormal_bone_marrow | 0.68420904 |
| 133 | MP0005164_abnormal_response_to | 0.68095974 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.68091137 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.67604636 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.66470489 |
| 137 | MP0005319_abnormal_enzyme/_coenzyme | 0.66422604 |
| 138 | MP0000266_abnormal_heart_morphology | 0.65595149 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.65406118 |
| 140 | MP0000383_abnormal_hair_follicle | 0.63879354 |
| 141 | MP0003252_abnormal_bile_duct | 0.63842491 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.61787996 |
| 143 | MP0003136_yellow_coat_color | 0.61719046 |
| 144 | MP0001175_abnormal_lung_morphology | 0.61214004 |
| 145 | MP0002938_white_spotting | 0.60781869 |
| 146 | MP0001661_extended_life_span | 0.60012804 |
| 147 | MP0008872_abnormal_physiological_respon | 0.59421224 |
| 148 | MP0008877_abnormal_DNA_methylation | 0.58472483 |
| 149 | MP0003937_abnormal_limbs/digits/tail_de | 0.58094726 |
| 150 | MP0002254_reproductive_system_inflammat | 0.57379268 |
| 151 | MP0002733_abnormal_thermal_nociception | 0.56692829 |
| 152 | MP0009115_abnormal_fat_cell | 0.56454574 |
| 153 | MP0010630_abnormal_cardiac_muscle | 0.56183130 |
| 154 | MP0005503_abnormal_tendon_morphology | 0.56094196 |
| 155 | MP0008770_decreased_survivor_rate | 0.53556651 |
| 156 | MP0005375_adipose_tissue_phenotype | 0.46746103 |
| 157 | MP0003300_gastrointestinal_ulcer | 0.45860460 |
| 158 | MP0003868_abnormal_feces_composition | 0.44206225 |
| 159 | MP0005174_abnormal_tail_pigmentation | 0.43411511 |
| 160 | MP0000427_abnormal_hair_cycle | 0.42564040 |
| 161 | MP0001186_pigmentation_phenotype | 0.42167497 |
| 162 | MP0000377_abnormal_hair_follicle | 0.41816542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Amelogenesis imperfecta (HP:0000705) | 8.29908087 |
| 2 | Thyroid-stimulating hormone excess (HP:0002925) | 7.92763952 |
| 3 | Acanthocytosis (HP:0001927) | 7.29910807 |
| 4 | Focal motor seizures (HP:0011153) | 7.03452662 |
| 5 | Congenital ichthyosiform erythroderma (HP:0007431) | 5.68598232 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 5.54684045 |
| 7 | Polycythemia (HP:0001901) | 5.40086300 |
| 8 | Parakeratosis (HP:0001036) | 4.92099767 |
| 9 | Petechiae (HP:0000967) | 4.69387418 |
| 10 | Hematochezia (HP:0002573) | 4.59429841 |
| 11 | Spontaneous hematomas (HP:0007420) | 4.49866350 |
| 12 | Esophageal varix (HP:0002040) | 4.38062455 |
| 13 | Aplastic anemia (HP:0001915) | 4.23549217 |
| 14 | Menorrhagia (HP:0000132) | 4.09944890 |
| 15 | Purpura (HP:0000979) | 3.99242561 |
| 16 | Poikilocytosis (HP:0004447) | 3.92500542 |
| 17 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.72499404 |
| 18 | Dialeptic seizures (HP:0011146) | 3.70683385 |
| 19 | Increased mean platelet volume (HP:0011877) | 3.57831288 |
| 20 | Abnormality of the hepatic vasculature (HP:0006707) | 3.49059498 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.47423029 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.43347724 |
| 23 | Vertebral arch anomaly (HP:0008438) | 3.43216648 |
| 24 | Portal hypertension (HP:0001409) | 3.39275677 |
| 25 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.39267826 |
| 26 | Intestinal atresia (HP:0011100) | 3.35794325 |
| 27 | Hyperglycinuria (HP:0003108) | 3.28937370 |
| 28 | Difficulty walking (HP:0002355) | 3.27030549 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 3.22275421 |
| 30 | Abnormal platelet volume (HP:0011876) | 3.16861764 |
| 31 | Volvulus (HP:0002580) | 3.13389008 |
| 32 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.06978620 |
| 33 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.06978620 |
| 34 | Conjunctival telangiectasia (HP:0000524) | 3.05114042 |
| 35 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.98458984 |
| 36 | Abnormality of the nasal mucosa (HP:0000433) | 2.95820369 |
| 37 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93913846 |
| 38 | Epistaxis (HP:0000421) | 2.91126776 |
| 39 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.90773634 |
| 40 | Chronic bronchitis (HP:0004469) | 2.87169369 |
| 41 | Proximal amyotrophy (HP:0007126) | 2.87028556 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.86791302 |
| 43 | Absent hand (HP:0004050) | 2.86219909 |
| 44 | Joint hemorrhage (HP:0005261) | 2.82338794 |
| 45 | Focal seizures (HP:0007359) | 2.69662734 |
| 46 | Aortic aneurysm (HP:0004942) | 2.66789780 |
| 47 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.62415211 |
| 48 | Chromsome breakage (HP:0040012) | 2.58187261 |
| 49 | Pulmonary artery stenosis (HP:0004415) | 2.57035035 |
| 50 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.54185148 |
| 51 | Poor head control (HP:0002421) | 2.52119727 |
| 52 | Lack of skin elasticity (HP:0100679) | 2.49943708 |
| 53 | Abnormality of the pulmonary veins (HP:0011718) | 2.47497835 |
| 54 | Oligodontia (HP:0000677) | 2.45902645 |
| 55 | Abnormality of abdominal situs (HP:0011620) | 2.45363978 |
| 56 | Abdominal situs inversus (HP:0003363) | 2.45363978 |
| 57 | Pigmentary retinal degeneration (HP:0001146) | 2.45169006 |
| 58 | Broad alveolar ridges (HP:0000187) | 2.44652129 |
| 59 | Scapular winging (HP:0003691) | 2.44219254 |
| 60 | Abnormality of the aortic arch (HP:0012303) | 2.44177908 |
| 61 | Pulmonary hypertension (HP:0002092) | 2.41340985 |
| 62 | Overlapping toe (HP:0001845) | 2.41221868 |
| 63 | Hyperglycinemia (HP:0002154) | 2.40303303 |
| 64 | Hyperthyroidism (HP:0000836) | 2.39109284 |
| 65 | Adactyly (HP:0009776) | 2.35523876 |
| 66 | Duplicated collecting system (HP:0000081) | 2.33932472 |
| 67 | Hyperkalemia (HP:0002153) | 2.32251383 |
| 68 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.31206307 |
| 69 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.31206307 |
| 70 | Single umbilical artery (HP:0001195) | 2.31206307 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 2.31036302 |
| 72 | Abnormality of the ileum (HP:0001549) | 2.30746533 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.30696378 |
| 74 | Ileus (HP:0002595) | 2.30625404 |
| 75 | Synostosis of carpal bones (HP:0005048) | 2.30467065 |
| 76 | Microcytic anemia (HP:0001935) | 2.30112715 |
| 77 | Meckel diverticulum (HP:0002245) | 2.29257555 |
| 78 | Erythroderma (HP:0001019) | 2.27631083 |
| 79 | Absent radius (HP:0003974) | 2.26628267 |
| 80 | Aplasia cutis congenita (HP:0001057) | 2.25932467 |
| 81 | Hyperlipoproteinemia (HP:0010980) | 2.24771430 |
| 82 | Gangrene (HP:0100758) | 2.24357619 |
| 83 | Vascular calcification (HP:0004934) | 2.24056955 |
| 84 | Shawl scrotum (HP:0000049) | 2.23663977 |
| 85 | Hydroureter (HP:0000072) | 2.23223399 |
| 86 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.23113414 |
| 87 | Ventricular tachycardia (HP:0004756) | 2.21900605 |
| 88 | Aortic dissection (HP:0002647) | 2.21639139 |
| 89 | Thickened helices (HP:0000391) | 2.20823809 |
| 90 | Abnormal hemoglobin (HP:0011902) | 2.19381983 |
| 91 | Abnormality of glycine metabolism (HP:0010895) | 2.19129342 |
| 92 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.19129342 |
| 93 | Growth hormone excess (HP:0000845) | 2.17053980 |
| 94 | Congenital, generalized hypertrichosis (HP:0004540) | 2.15338514 |
| 95 | Ulnar bowing (HP:0003031) | 2.14961625 |
| 96 | Rectal prolapse (HP:0002035) | 2.13618385 |
| 97 | Thickened calvaria (HP:0002684) | 2.12894126 |
| 98 | Breast hypoplasia (HP:0003187) | 2.09654416 |
| 99 | Dehydration (HP:0001944) | 2.08259647 |
| 100 | Capillary hemangiomas (HP:0005306) | 2.06992098 |
| 101 | Embryonal renal neoplasm (HP:0011794) | 2.06652564 |
| 102 | Testicular atrophy (HP:0000029) | 2.06460658 |
| 103 | Aplasia involving forearm bones (HP:0009822) | 2.06112046 |
| 104 | Absent forearm bone (HP:0003953) | 2.06112046 |
| 105 | Tubular atrophy (HP:0000092) | 2.05934974 |
| 106 | Cerebellar dysplasia (HP:0007033) | 2.05227977 |
| 107 | Ectropion (HP:0000656) | 2.04676132 |
| 108 | Long foot (HP:0001833) | 2.04247672 |
| 109 | Abnormality of the renal collecting system (HP:0004742) | 2.03797017 |
| 110 | Broad ribs (HP:0000885) | 2.03523614 |
| 111 | Central scotoma (HP:0000603) | 2.02906856 |
| 112 | Colon cancer (HP:0003003) | 2.01650788 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.01039380 |
| 114 | Renal cortical cysts (HP:0000803) | 2.01004571 |
| 115 | Gingival bleeding (HP:0000225) | 2.00929633 |
| 116 | Enlarged kidneys (HP:0000105) | 1.99274827 |
| 117 | Cerebral aneurysm (HP:0004944) | 1.98083626 |
| 118 | Anal stenosis (HP:0002025) | 1.97481188 |
| 119 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.97258127 |
| 120 | Gastrointestinal carcinoma (HP:0002672) | 1.97258127 |
| 121 | Hypoglycemic coma (HP:0001325) | 1.97127922 |
| 122 | Abnormal pupillary function (HP:0007686) | 1.96653060 |
| 123 | Septo-optic dysplasia (HP:0100842) | 1.95721329 |
| 124 | Testicular neoplasm (HP:0010788) | 1.95689187 |
| 125 | Azoospermia (HP:0000027) | 1.95235441 |
| 126 | Hypoplastic iliac wings (HP:0002866) | 1.95182019 |
| 127 | Tachypnea (HP:0002789) | 1.95157392 |
| 128 | Progressive inability to walk (HP:0002505) | 1.95070766 |
| 129 | Abnormality of the intrinsic pathway (HP:0010989) | 1.94823188 |
| 130 | Distal lower limb muscle weakness (HP:0009053) | 1.94262593 |
| 131 | Porencephaly (HP:0002132) | 1.94206075 |
| 132 | Stroke (HP:0001297) | 1.94175208 |
| 133 | Nonprogressive disorder (HP:0003680) | 1.93672234 |
| 134 | Large for gestational age (HP:0001520) | 1.92372647 |
| 135 | Tarsal synostosis (HP:0008368) | 1.92165389 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.92073046 |
| 137 | Deep venous thrombosis (HP:0002625) | 1.91640624 |
| 138 | Facial cleft (HP:0002006) | 1.90770017 |
| 139 | Mesomelia (HP:0003027) | 1.89071670 |
| 140 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88436769 |
| 141 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88301495 |
| 142 | Onycholysis (HP:0001806) | 1.87472608 |
| 143 | Hyperpituitarism (HP:0010514) | 1.87254690 |
| 144 | Visceral angiomatosis (HP:0100761) | 1.87016893 |
| 145 | Nausea (HP:0002018) | 1.86601819 |
| 146 | Abnormality of the vocal cords (HP:0008777) | 1.85871627 |
| 147 | Non-midline cleft lip (HP:0100335) | 1.85134661 |
| 148 | Hyperammonemia (HP:0001987) | 1.85009568 |
| 149 | Absent eyebrow (HP:0002223) | 1.82847914 |
| 150 | Abnormal spermatogenesis (HP:0008669) | 1.82650414 |
| 151 | Skull defect (HP:0001362) | 1.82554903 |
| 152 | Pendular nystagmus (HP:0012043) | 1.81517349 |
| 153 | Abnormality of macular pigmentation (HP:0008002) | 1.81515290 |
| 154 | Renal salt wasting (HP:0000127) | 1.81387008 |
| 155 | Severe visual impairment (HP:0001141) | 1.80889661 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.80434315 |
| 157 | Agitation (HP:0000713) | 1.78193795 |
| 158 | Atrioventricular block (HP:0001678) | 1.77683956 |
| 159 | Redundant skin (HP:0001582) | 1.77320541 |
| 160 | Dysmetric saccades (HP:0000641) | 1.76218800 |
| 161 | Scotoma (HP:0000575) | 1.75977990 |
| 162 | Supernumerary spleens (HP:0009799) | 1.75509602 |
| 163 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75122857 |
| 164 | Subcapsular cataract (HP:0000523) | 1.74810192 |
| 165 | Hemangiomatosis (HP:0007461) | 1.74204820 |
| 166 | Muscle fibrillation (HP:0010546) | 1.73798814 |
| 167 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73037561 |
| 168 | Facial shape deformation (HP:0011334) | 1.72788931 |
| 169 | Potter facies (HP:0002009) | 1.72788931 |
| 170 | Osteomalacia (HP:0002749) | 1.72753656 |
| 171 | Ureteral duplication (HP:0000073) | 1.71954240 |
| 172 | Neonatal death (HP:0003811) | 1.71869180 |
| 173 | Absent toe (HP:0010760) | 1.71676799 |
| 174 | Mesangial abnormality (HP:0001966) | 1.71473620 |
| 175 | Dicarboxylic aciduria (HP:0003215) | 1.70502288 |
| 176 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70502288 |
| 177 | Bruising susceptibility (HP:0000978) | 1.69602147 |
| 178 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.69464686 |
| 179 | Abnormality of serum amino acid levels (HP:0003112) | 1.69098003 |
| 180 | Hyperaldosteronism (HP:0000859) | 1.68424162 |
| 181 | Radial bowing (HP:0002986) | 1.66699680 |
| 182 | Horizontal nystagmus (HP:0000666) | 1.66271927 |
| 183 | Median cleft lip (HP:0000161) | 1.65898541 |
| 184 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.65785145 |
| 185 | Congenital hepatic fibrosis (HP:0002612) | 1.65346611 |
| 186 | Congenital stationary night blindness (HP:0007642) | 1.64047136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.42121528 |
| 2 | KDR | 4.73799818 |
| 3 | TGFBR2 | 3.85936977 |
| 4 | GRK1 | 3.00744754 |
| 5 | EPHA2 | 2.91306319 |
| 6 | AKT3 | 2.80640139 |
| 7 | STK38L | 2.64392377 |
| 8 | MYLK | 2.48002996 |
| 9 | PRKD3 | 2.30865421 |
| 10 | MELK | 2.15125111 |
| 11 | ZAK | 1.97355796 |
| 12 | MAP2K2 | 1.87739456 |
| 13 | IRAK3 | 1.87341398 |
| 14 | PDK2 | 1.82390371 |
| 15 | EIF2AK2 | 1.57148069 |
| 16 | EPHB2 | 1.53462037 |
| 17 | BMPR1B | 1.48339581 |
| 18 | INSRR | 1.45546024 |
| 19 | TGFBR1 | 1.45050808 |
| 20 | MAP3K3 | 1.40785073 |
| 21 | RIPK1 | 1.37492324 |
| 22 | PINK1 | 1.36135303 |
| 23 | TTN | 1.23734800 |
| 24 | TAOK2 | 1.23267934 |
| 25 | LATS1 | 1.20946575 |
| 26 | MAP3K2 | 1.18064865 |
| 27 | BUB1 | 1.15189484 |
| 28 | PDPK1 | 1.15033610 |
| 29 | ERN1 | 1.14581033 |
| 30 | ADRBK1 | 1.14314567 |
| 31 | BCKDK | 1.04647360 |
| 32 | PDK4 | 1.03936673 |
| 33 | PDK3 | 1.03936673 |
| 34 | FER | 1.03741916 |
| 35 | MAP2K3 | 0.99709770 |
| 36 | NLK | 0.99402692 |
| 37 | LMTK2 | 0.99074020 |
| 38 | PBK | 0.96892958 |
| 39 | TTK | 0.95818474 |
| 40 | WEE1 | 0.95209620 |
| 41 | PLK4 | 0.93296437 |
| 42 | GRK5 | 0.91783520 |
| 43 | NME1 | 0.90149404 |
| 44 | KSR2 | 0.89237058 |
| 45 | SRPK1 | 0.87297436 |
| 46 | MAP3K11 | 0.87156549 |
| 47 | BMX | 0.85784301 |
| 48 | TEC | 0.83753664 |
| 49 | PRKG2 | 0.82677179 |
| 50 | MST4 | 0.82139296 |
| 51 | MAPK7 | 0.81776848 |
| 52 | FGFR4 | 0.79590757 |
| 53 | PAK4 | 0.74795095 |
| 54 | TAF1 | 0.73664881 |
| 55 | MAPK15 | 0.69857013 |
| 56 | MST1R | 0.68786902 |
| 57 | MAP2K1 | 0.68426854 |
| 58 | PIK3CG | 0.67307736 |
| 59 | CSK | 0.65697455 |
| 60 | PLK1 | 0.63345127 |
| 61 | PRKAA2 | 0.60198093 |
| 62 | EIF2AK1 | 0.59734022 |
| 63 | PRKD1 | 0.59497371 |
| 64 | STK16 | 0.59172112 |
| 65 | CSNK1A1L | 0.57183907 |
| 66 | MKNK2 | 0.54852018 |
| 67 | CDK3 | 0.54153025 |
| 68 | MAP3K6 | 0.52126177 |
| 69 | NUAK1 | 0.51477737 |
| 70 | PNCK | 0.51364055 |
| 71 | IRAK1 | 0.50435729 |
| 72 | STK3 | 0.49637647 |
| 73 | MET | 0.49239231 |
| 74 | CAMK1G | 0.48933793 |
| 75 | TYRO3 | 0.48593111 |
| 76 | CDK12 | 0.48463025 |
| 77 | AURKB | 0.46693299 |
| 78 | GRK7 | 0.46230977 |
| 79 | YES1 | 0.45944345 |
| 80 | AKT2 | 0.45158640 |
| 81 | CASK | 0.44325337 |
| 82 | STK10 | 0.43891825 |
| 83 | ERBB4 | 0.43530692 |
| 84 | CAMK1D | 0.43280070 |
| 85 | CDK7 | 0.42173349 |
| 86 | BRSK2 | 0.40903335 |
| 87 | STK39 | 0.40378362 |
| 88 | GSK3A | 0.39721215 |
| 89 | PTK2B | 0.39357024 |
| 90 | RPS6KA4 | 0.38540162 |
| 91 | EIF2AK3 | 0.37558375 |
| 92 | EEF2K | 0.36347065 |
| 93 | DYRK3 | 0.35867672 |
| 94 | ACVR1B | 0.35597227 |
| 95 | DDR2 | 0.35310090 |
| 96 | TSSK6 | 0.34511214 |
| 97 | STK24 | 0.33641207 |
| 98 | PIM1 | 0.32714439 |
| 99 | CDK6 | 0.31289488 |
| 100 | CHEK2 | 0.30082089 |
| 101 | LATS2 | 0.29296661 |
| 102 | PRKCI | 0.28369630 |
| 103 | CSNK2A1 | 0.28074708 |
| 104 | STK38 | 0.27968281 |
| 105 | OBSCN | 0.27219442 |
| 106 | PTK2 | 0.27196419 |
| 107 | BRD4 | 0.26995501 |
| 108 | PRKAA1 | 0.26770622 |
| 109 | MAP3K14 | 0.25546336 |
| 110 | PDGFRA | 0.24786032 |
| 111 | MAP2K6 | 0.24575500 |
| 112 | OXSR1 | 0.24489862 |
| 113 | IGF1R | 0.23649951 |
| 114 | PRKCG | 0.23586835 |
| 115 | PIM2 | 0.23571277 |
| 116 | BCR | 0.23198733 |
| 117 | MAPK12 | 0.22848597 |
| 118 | MAPK11 | 0.22767925 |
| 119 | CSF1R | 0.22558357 |
| 120 | PHKG1 | 0.22291503 |
| 121 | PHKG2 | 0.22291503 |
| 122 | NEK2 | 0.21961613 |
| 123 | MAPKAPK3 | 0.21486165 |
| 124 | PDK1 | 0.20524952 |
| 125 | NEK9 | 0.20414801 |
| 126 | STK4 | 0.20139339 |
| 127 | TXK | 0.19897725 |
| 128 | MARK3 | 0.19224273 |
| 129 | PRKCE | 0.19221379 |
| 130 | ADRBK2 | 0.19217948 |
| 131 | CAMK2G | 0.18926983 |
| 132 | BTK | 0.18649494 |
| 133 | MAPK3 | 0.18172872 |
| 134 | FRK | 0.18044804 |
| 135 | RET | 0.17446946 |
| 136 | RIPK4 | 0.17304024 |
| 137 | TNK2 | 0.15889533 |
| 138 | MOS | 0.15226278 |
| 139 | MAPK1 | 0.12780813 |
| 140 | PDGFRB | 0.12447805 |
| 141 | CSNK1D | 0.12053055 |
| 142 | ABL1 | 0.10105159 |
| 143 | ERBB2 | 0.09902590 |
| 144 | PKN2 | 0.09007023 |
| 145 | CDK9 | 0.07624348 |
| 146 | AKT1 | 0.07256804 |
| 147 | NEK6 | 0.06508556 |
| 148 | CAMK2A | 0.06129297 |
| 149 | MAP3K8 | 0.05819949 |
| 150 | TAOK3 | 0.05249484 |
| 151 | DAPK3 | 0.04978066 |
| 152 | WNK4 | 0.04924007 |
| 153 | SMG1 | 0.04199641 |
| 154 | DAPK2 | 0.02685973 |
| 155 | PLK2 | 0.02208906 |
| 156 | MAPKAPK5 | 0.01077483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.70600824 |
| 2 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 3.59002809 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.17744656 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.10030951 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.88351204 |
| 6 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.73827566 |
| 7 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.43586913 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40322771 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.07927123 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07825069 |
| 11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.07728909 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05346302 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.03639628 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.03314307 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02526544 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.01840324 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 2.00715652 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00534761 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97581137 |
| 20 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.95604764 |
| 21 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.85762612 |
| 22 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.84810734 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.82491742 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.78020352 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74300448 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73804956 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.71263238 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66494555 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.66434401 |
| 30 | Homologous recombination_Homo sapiens_hsa03440 | 1.64336609 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.62756423 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61158112 |
| 33 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.59149959 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.58236999 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.57418475 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51235923 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50843720 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.50323806 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38849879 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37480114 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34896368 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.33354776 |
| 43 | Purine metabolism_Homo sapiens_hsa00230 | 1.31882977 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.31627120 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 1.26208910 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.23675962 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.21692609 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20703439 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20081188 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 1.19852280 |
| 51 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19359342 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19188133 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.18009725 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17667691 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.16505093 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10417131 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10152683 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10072522 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.09842841 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05675197 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05429522 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04107658 |
| 63 | Tight junction_Homo sapiens_hsa04530 | 1.02297522 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01342869 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00172679 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.99089260 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.97065062 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96806200 |
| 69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96511616 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96453823 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.94571194 |
| 72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93558842 |
| 73 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.93543526 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92970080 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91950358 |
| 76 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90573143 |
| 77 | DNA replication_Homo sapiens_hsa03030 | 0.90434379 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.89960320 |
| 79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88076502 |
| 80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87890053 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85584139 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85255957 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.84814075 |
| 84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84744873 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.82304465 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.79892317 |
| 87 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79342145 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78543210 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77483410 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76166090 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76139361 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.76094152 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75160221 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72234976 |
| 95 | Spliceosome_Homo sapiens_hsa03040 | 0.71296098 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71091640 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70582244 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70320882 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70093864 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.69582178 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69499671 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69249941 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68606552 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68064266 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67831810 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67685185 |
| 107 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.67497771 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66530158 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.65933845 |
| 110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64708396 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.64379000 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62968273 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62301927 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.62088992 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.60441206 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58699487 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58290870 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58241393 |
| 119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58131051 |
| 120 | Gap junction_Homo sapiens_hsa04540 | 0.57937417 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57316083 |
| 122 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57180996 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56688471 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56375226 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.55229711 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54776521 |
| 127 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54645931 |
| 128 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53450899 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.51915187 |
| 130 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51398578 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.51093963 |
| 132 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50223662 |
| 133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50166537 |
| 134 | Malaria_Homo sapiens_hsa05144 | 0.49257443 |
| 135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48108786 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48035317 |
| 137 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47901431 |
| 138 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.46901351 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.46613537 |
| 140 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45582484 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45518838 |
| 142 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45313265 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43919876 |
| 144 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43786740 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42575273 |
| 146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42233743 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41973196 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40776792 |
| 149 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39219409 |
| 150 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39154459 |
| 151 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37567659 |
| 152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.36465119 |
| 153 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34373294 |
| 154 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.33512818 |
| 155 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33424007 |
| 156 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32352264 |
| 157 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32210230 |
| 158 | Cell cycle_Homo sapiens_hsa04110 | 0.28802924 |
| 159 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28405102 |

